US regulators approve new tuberculosis drug

US health regulators said Monday they had licensed a new treatment for multidrug-resistant tuberculosis — the first such federal approval aimed at tackling the deadly disease in 40 years.

US health regulators said Monday they had licensed a new treatment for multidrug-resistant tuberculosis — the first such federal approval aimed at tackling the deadly disease in 40 years.